Clonal architecture of chronic myelomonocytic leukemiasRaphaël Itzykson, Éric Solary, Lionel Adès et al.|Blood|2013Cited by 268
Prognostic impact of<i>DDX41</i>germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO studyNicolas Duployez, Marie Sébert, Laëtitia Largeaud et al.|Blood|2022Cited by 80
Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapyMarco Cerrano, Raphaël Itzykson, Matthieu Duchmann et al.|Leukemia|2020Cited by 20